focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Cuts Antofagasta, Raises Anglo American

Fri, 23rd Jan 2015 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES REED ELSEVIER PRICE TARGET TO 1275 (1105) PENCE - 'BUY'
----------
SOCGEN RAISES WPP PRICE TARGET TO 1685 (1530) PENCE - 'BUY'
----------
SOCGEN RAISES PEARSON PRICE TARGET TO 1220 (1105) PENCE - 'HOLD'
----------
SOCGEN RAISES ITV PRICE TARGET TO 240 (220) PENCE - 'HOLD'
----------
SOCGEN RAISES SKY PLC PRICE TARGET TO 1110 (1045) PENCE - 'BUY'
----------
BERENBERG CUTS CENTRICA PRICE TARGET TO 300 (370) PENCE - 'BUY'
----------
BERNSTEIN CUTS HSBC PRICE TARGET TO 660 (800) PENCE - 'OUTPERFORM'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4800 (4240) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1620 (1540) PENCE - 'HOLD'
----------
BERENBERG CUTS INTERTEK PRICE TARGET TO 2375 (2800) PENCE - 'HOLD'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 939 (916) PENCE - 'OVERWEIGHT'
----------
TRADERS: GOLDMAN CUTS ANTOFAGASTA TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 710 (755) PENCE - 'NEUTRAL'
----------
TRADERS: GOLDMAN RAISES ANGLO AMERICAN TO 'NEUTRAL' ('SELL')
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 1120 (1340) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS EXPERIAN TO 'NEUTRAL' ('BUY')
----------
CITIGROUP RAISES ST JAMES'S PLACE PRICE TARGET TO 1000 (870) PENCE - 'BUY'
----------
NUMIS RAISES ST JAMES'S PLACE PRICE TARGET TO 980 (850) PENCE - 'ADD'
----------
CITIGROUP CUTS WEIR GROUP PRICE TARGET TO 1750 (1900) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES IAG PRICE TARGET TO 7.50 (6.60) EUR - 'OVERWEIGHT'
----------
NUMIS RAISES WHITBREAD PRICE TARGET TO 5600 (5150) PENCE - 'ADD'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES COMPASS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FRESNILLO PRICE TARGET TO 1190 (1110) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES INTERCONTINENTAL HOTELS TARGET TO 2600 (2200) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1550 (1870) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS RIO TINTO PRICE TARGET TO 3400 (3500) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
JPMORGAN RAISES BETFAIR PRICE TARGET TO 1600 (1510) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES BALFOUR BEATTY TO 'ADD' ('HOLD') - TARGET 230 PENCE
----------
SOCGEN RAISES INFORMA TO 'BUY' ('HOLD') - TARGET 585 (500) PENCE
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 950 (1300) PENCE - 'BUY'
----------
BERENBERG CUTS OXFORD INSTRUMENTS TO 'HOLD' ('BUY') - TARGET 950 (1360) PENCE

BARCLAYS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 860 (1140) PENCE - 'EQUALWEIGHT'

JPMORGAN CUTS OXFORD INSTRUMENTS TARGET TO 1200 (1350) PENCE - 'OVERWEIGHT'

UBS CUTS RENTOKIL INITIAL TO 'SELL' ('NEUTRAL') - TARGET 112 PENCE
----------
UBS CUTS OPHIR ENERGY PRICE TARGET TO 150 (230) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ELECTROCOMPONENTS PRICE TARGET TO 210 (229) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS CUTS PREMIER FARNELL PRICE TARGET TO 188 (205) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: JPMORGAN CUTS TELECITY GROUP TO 'NEUTRAL' ('OVERWEIGHT')
----------
TRADERS: MORGAN STANLEY CUTS MICHAEL PAGE TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
UBS CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS CRODA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2770 (2820) PENCE
----------
EXANE BNP CUTS ELEMENTIS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 300 PENCE
----------
CITIGROUP RAISES HENDERSON GROUP PLC PRICE TARGET TO 246 (218) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HAYS PRICE TARGET TO 165 (160) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS TELECITY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 900 (925) PENCE
----------
JPMORGAN RAISES LADBROKES PRICE TARGET TO 110 (95) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PLAYTECH PRICE TARGET TO 635 (615) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SSP GROUP PRICE TARGET TO 320 (310) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 335 (365) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS VEDANTA PRICE TARGET TO 530 (960) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
SOCGEN CUTS DAILY MAIL PRICE TARGET TO 720 (740) PENCE - 'SELL'
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 130 (125) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS FERREXPO PRICE TARGET TO 80 (110) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS PETROPAVLOVSK PRICE TARGET TO 9 (10) PENCE - 'UNDERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.